United Therapeutics Corp (UTHR)

Oct 05, 2025

Is There Still an Opportunity in United Therapeutics After Its 25.8% Year to Date Surge? - simplywall.st

Oct 05, 2025

Oct 03, 2025

How Positive TETON-2 Results for Tyvaso Have Changed United Therapeutics' (UTHR) Investment Story - simplywall.st

Oct 03, 2025

Oct 03, 2025

News impact scoring models applied to United Therapeutics CorporationPortfolio Growth Summary & Weekly Top Gainers Alerts - newser.com

Oct 03, 2025

Oct 02, 2025

United Therapeutics stock hits all-time high at 442.02 USD - Investing.com

Oct 02, 2025

Oct 02, 2025

United Therapeutics stock hits all-time high at 442.02 USD By Investing.com - Investing.com South Africa

Oct 02, 2025

Oct 02, 2025

TD Cowen maintains Buy rating on United Therapeutics stock, citing IPF opportunity - Investing.com

Oct 02, 2025

Oct 02, 2025

Jefferies reiterates Buy rating on United Therapeutics stock amid patent case - Investing.com

Oct 02, 2025

Oct 02, 2025

UBS maintains United Therapeutics stock Buy rating amid patent litigation By Investing.com - Investing.com Canada

Oct 02, 2025

Oct 01, 2025

United Therapeutics COO sells $9.49m in UTHR stock By Investing.com - Investing.com South Africa

Oct 01, 2025

Oct 01, 2025

United Therapeutics COO sells $9.49m in UTHR stock - Investing.com India

Oct 01, 2025

Oct 01, 2025

Is IPF the Next Big Market Opportunity for United Therapeutics? - Yahoo Finance

Oct 01, 2025

Oct 01, 2025

UBS maintains United Therapeutics stock Buy rating amid patent litigation - Investing.com India

Oct 01, 2025

Sep 30, 2025

United Therapeutics president Michael Benkowitz sells shares worth $3.65m - MSN

Sep 30, 2025

Sep 29, 2025

United Therapeutics stock price target raised to $580 by UBS on Tyvaso outlook - Investing.com Australia

Sep 29, 2025

Sep 29, 2025

United Therapeutics Corp. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo

Sep 29, 2025

Sep 29, 2025

United Therapeutics stock maintains Buy rating at H.C. Wainwright amid patent case developments - Investing.com Australia

Sep 29, 2025

Sep 29, 2025

United Therapeutics (UTHR): UBS Raises Price Target to $580, Mai - GuruFocus

Sep 29, 2025

Sep 29, 2025

United Therapeutics stock maintains Buy rating at H.C. Wainwright amid patent case developments By Investing.com - Investing.com Australia

Sep 29, 2025

Sep 29, 2025

Will United Therapeutics Corporation (UTH) stock beat international competitionWeekly Trade Review & Reliable Trade Execution Plans - newser.com

Sep 29, 2025

Sep 29, 2025

United Therapeutics stock holds Buy rating at TD Cowen on strong IPF data - Investing.com Canada

Sep 29, 2025

Sep 29, 2025

United Therapeutics stock holds Buy rating at TD Cowen on strong IPF data By Investing.com - Investing.com South Africa

Sep 29, 2025

Sep 29, 2025

United Therapeutics Corporation $UTHR Holdings Lifted by State of Alaska Department of Revenue - MarketBeat

Sep 29, 2025

Sep 28, 2025

Why United Therapeutics Corporation (UTH) stock stays undervaluedTrade Ideas & Verified Chart Pattern Trade Signals - newser.com

Sep 28, 2025

Sep 28, 2025

Analyzing drawdowns of United Therapeutics Corporation with statistical tools2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com

Sep 28, 2025

Sep 28, 2025

Why United Therapeutics Corporation (UTH) stock gets analyst attention2025 Winners & Losers & Low Risk Investment Opportunities - newser.com

Sep 28, 2025

Sep 27, 2025

Chart based analysis of United Therapeutics Corporation trendsInsider Selling & Real-Time Stock Movement Alerts - newser.com

Sep 27, 2025

Sep 27, 2025

Augustine Asset Management Inc. Makes New Investment in United Therapeutics Corporation $UTHR - MarketBeat

Sep 27, 2025

Sep 27, 2025

Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR) and Zai Lab (ZLAB) - The Globe and Mail

Sep 27, 2025

Sep 26, 2025

United Therapeutics Rides Tyvaso Wins To Major Gains - Finimize

Sep 26, 2025

Sep 26, 2025

RBC Capital initiates United Therapeutics stock with Outperform rating By Investing.com - Investing.com Canada

Sep 26, 2025

Sep 26, 2025

RBC Capital Initiates Coverage on United Therapeutics (UTHR) wit - GuruFocus

Sep 26, 2025

Sep 26, 2025

This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Sep 26, 2025

Sep 26, 2025

Sowell Financial Services LLC Invests $333,000 in United Therapeutics Corporation $UTHR - MarketBeat

Sep 26, 2025

Sep 26, 2025

RBC Capital initiates United Therapeutics stock with Outperform rating - Investing.com

Sep 26, 2025

Sep 25, 2025

Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Sep 25, 2025

Sep 25, 2025

Rothblatt, United Therapeutics CEO, sells $3.4m in UTHR stock By Investing.com - Investing.com Nigeria

Sep 25, 2025

Sep 25, 2025

Insider Sell: Christopher Causey Sells 1,000 Shares of United Th - GuruFocus

Sep 25, 2025

Sep 25, 2025

Rothblatt, United Therapeutics CEO, sells $3.4m in UTHR stock - Investing.com India

Sep 25, 2025

Sep 25, 2025

United Therapeutics Corp. Hits New 52-Week High of $442.01 - Markets Mojo

Sep 25, 2025

Sep 25, 2025

United Therapeutics Corporation $UTHR Shares Sold by Ruffer LLP - MarketBeat

Sep 25, 2025